Custom Pitch Deck Design Services for Pharma & Biotech Founders
- Ink Narrates | The Presentation Design Agency
- Feb 7, 2025
- 4 min read
Updated: 6 days ago
Your drug might save lives. Your deck is killing the round.
Most pharmaceutical pitch decks read like a regulatory submission someone forgot to finish. We build pharma and biotech pitch decks that respect the science and still make capital allocators lean forward.
Investors don't reject your pharmaceutical pitch deck because of the science. They reject the story.
And the brutal part is this: the deck that wins isn't usually the one with the best science.
It's the one with the clearest argument. The one that doesn't make a portfolio manager translate from immunology back into English on slide seven. The one that doesn't bury the mechanism under four pages of pipeline charts and a confusing logo grid of CROs.
You can disagree with this. A lot of brilliant scientists do.
But disagreeing with it doesn't make it less true — it just makes your raise harder. Most pharmaceutical pitch deck services either understand the science and can't tell a story, or can tell a story and butcher the science. The gap between those two things is where most rounds quietly die.
Your job isn't to teach the room. It's to make them want to fund you so they can learn the rest later.
Pharma and biotech pitch decks for the moments that cost real money to get wrong.
Series A → Crossover Rounds
Investor decks for venture and crossover rounds. Built around your asset's strongest argument, not a template that worked for someone else's mRNA company in 2021.
BD & Licensing Decks
The deck you bring to a Top 20 pharma BD team. Tight, defensible, no oversell. The kind that ends with a term sheet conversation instead of a polite follow-up email.
Data Readout Updates
Phase Ib results just dropped. Your existing deck is now obsolete. We rebuild the narrative around the new data in days, not weeks, without losing your prior investors in the rewrite.
Board & Strategic Reviews
Internal decks for board meetings, strategic pivots, or asset prioritization conversations. Less polish, more honesty, more usable thinking.
Conference & Roadshow Decks
Versions optimized for JPM week, BIO, and one-on-one investor meetings. Different audience, different room, different deck. We build all three.
IPO & Public Market Decks
Pre-IPO testing-the-waters decks and post-IPO investor updates that comply with disclosure rules without sounding like they were written by a frightened lawyer.
It's almost never the science.
We've reviewed hundreds of pharmaceutical decks before clients hire us. The same six failure modes show up in roughly the same order. None of them are about the molecule. All of them are fixable.
01
The deck buries the lede
Slide 14 is the one that should be slide 2. The single sentence that makes your asset worth funding is hiding behind a corporate timeline and a team photo.
02
Mechanism gets explained twice, market never gets explained once
Half the deck is the science. Three slides are the commercial argument. Investors are buying both.
03
Comparable assets are weak or missing
If you can't point to who you look like, who you don't look like, and why, you're asking the room to do unpaid analyst work.
04
The data slide is unreadable
Forest plots at 9pt. Axes with no units. A waterfall chart inverted. We see this every week.
05
The ask is fuzzy
You want 'around 30 to 50 million.' For 'about 18 to 24 months of runway.' To do 'a few things.' That's not an ask. That's a wish.
06
The deck contradicts itself
Slide 6 says blockbuster potential. Slide 19 says addressable population of 12,000 patients. Pick one. Defend it.
A pharmaceutical pitch deck service that works like a second brain for your raise.
Most pharmaceutical pitch deck services are essentially designers who Googled "Phase II" once.
We're the opposite. We push back on a slide, it isn't an aesthetic opinion.
It's because we've watched a Tiger Cubs analyst quietly close a deck at exactly that slide and we'd rather you not learn that lesson live.
We are also, honestly, willing to tell you things your team won't.
That your scientific founder's narrative is unfocused. That your TAM math is generous. That your competitive slide is dishonest. None of this is fun to hear. All of it is cheaper to hear from us than from a partner at a fund you've been chasing for nine months.
Frequently asked questions about our pharma & biotech pitch deck services.
Will you write the science, or do I provide it?
You provide the science. You and your team know your molecule better than anyone on earth. Our job is to make sure the right scientific points land with the right audience, in the right order, without watering anything down or overselling.
Do you sign NDAs?
Yes, we do. We follow a company-wide non-disclosure policy and treat every project as confidential by default. If you’d like us to sign a specific NDA, feel free to get in touch and we’ll review and sign it before the project begins.
What if I’d like to get started from scratch?
That's absolutely fine. If you don’t have content, a clear structure, or even a rough idea yet, we can help build the presentation from the ground up. We work with you to understand your goals, audience, and key message, then develop the storyline, slide structure, content flow, and visual direction from scratch.
Whether you need a pitch deck, sales presentation, company profile, or keynote, we help turn early-stage ideas into a polished presentation that communicates clearly and leaves a strong impression.
You have one shot at the first slide of your pharmaceutical pitch deck. Don't waste it.
The process to hire us is extremely easy. Just click on the "Start a Project" button on our website, calculate the price, make payment, and we'll take it from there. We look forward to working with you!